<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4242754</article-id><article-id pub-id-type="publisher-id">1470-7330-14-S1-S9</article-id><article-id pub-id-type="doi">10.1186/1470-7330-14-S1-S9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Scientific Session Presentation</subject></subj-group></article-categories><title-group><article-title>Whole-body diffusion-weighted imaging for staging lymphoma: are apparent diffusion coefficient derived histogram parameters useful for lesion characterisation?</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>De Paepe</surname><given-names>K</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>katja.depaepe@uzleuven.be</email></contrib><contrib contrib-type="author" id="A2"><name><surname>De Keyzer</surname><given-names>F</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Wolter</surname><given-names>P</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Bechter</surname><given-names>O</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Janssens</surname><given-names>A</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Dierickx</surname><given-names>D</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Oyen</surname><given-names>R</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Verhoef</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Vandecaveye</surname><given-names>V</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>University Hospitals Leuven, Leuven, Belgium</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2014</year></pub-date><volume>14</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.</named-content></supplement><fpage>S9</fpage><lpage>S9</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 De Paepe et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>De Paepe et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/14/S1/S9"/><conference><conf-date>9-11 October 2014</conf-date><conf-name>International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</conf-name><conf-loc>Heidelberg, Germany</conf-loc></conference></article-meta></front><body><sec><title>Aim</title><p>To evaluate apparent diffusion coefficient (ADC) derived histogram parameters for lesion characterization in whole-body diffusion-weighted imaging (WB-DWI) of lymphoma.</p></sec><sec sec-type="methods"><title>Methods</title><p>Fifteen patients with histopathology proven lymphoma (11 Non-Hodgkin; 4 Hodgkin lymphomas) underwent WB-DWI using 2 b-values (0-1000 s/mm<sup>2</sup>). On coronal reformatted b1000 WB-DWI images, regions of interest (ROI) were drawn semi-automatically on lymph nodes in all nodal stations (n=267) and in axial and appendicular bone regions (n=53). For each ROI, a histogram was constructed from which volume, mean<sub>(ADC)</sub>, median<sub>(ADC)</sub>, skewness<sub>(ADC)</sub>, and kurtosis<sub>(ADC)</sub> were calculated. Mann-Whitney-U tests were performed to detect significant differences between malignant and benign ROIs per tissue type. Receiver-operating-characteristic curves (ROC) were constructed from which an optimal threshold was determined as well as sensitivity, specificity and accuracy. PET/CT plus bone marrow biopsy (BMB) served as reference standard.</p></sec><sec sec-type="results"><title>Results</title><p>All parameters were significantly different between malignant and benign lymph nodes (p&#x0003c;0.001) with skewness<sub>(ADC)</sub> being the most accurate. A positive skewness exceeding 0.3041 mm<sup>2</sup>/s allowed for detection of malignant lymph nodes with 88% accuracy, 88% sensitivity and 87% specificity compared to 63% accuracy, 61% sensitivity and 64% specificity for mean<sub>(ADC)</sub>. Only kurtosis<sub>(ADC)</sub> (p&#x0003c;0.001) and skewness<sub>(ADC)</sub> (p=0.003) were significantly different between malignant bone marrow infiltration and normal bone marrow. Kurtosis<sub>(ADC)</sub> showed highest accuracy and a threshold exceeding 5.26 allowed for detection of malignant bone marrow infiltration with 89% accuracy, 86% sensitivity and 90% specificity.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>ADC histogram analysis is feasible for lesion characterization in WB-DWI of lymphoma. Lymph nodes were most accurately characterized using skewness<sub>(ADC)</sub> and bone tissue using kurtosis<sub>(ADC)</sub>.</p></sec></body></article>